Training for Systems Change: Addressing Tobacco and Behavioral Health 2021

People affected by mental illness and/or a substance use disorder smoke at far higher rates than the general public. Despite this, they are less likely to make quit attempts using evidence-based treatment.  There is a compelling need to integrate tobacco policy and tobacco dependence treatment into the behavioral healthcare system. These two courses address this need. Through these courses, you will learn how to successfully address tobacco in your clinical setting.   

To see why this training is so important, watch this 40 second video:

 

Target Audience

Practitioners who provide health care to people with mental illness/substance abuse disorders, obligated to address the nicotine addiction of their patients as part of their scope of practice, including physicians, nurses, physician assistants, social workers, and mental health and substance abuse providers. Program Directors and Quality Improvement staff will also benefit from this activity, as they are obligated to adopt policies regarding the use of tobacco.

Learning Objectives

Upon completion of this activity, learners will:

  1. Be able to articulate what constitutes evidence-based tobacco dependence treatment
  2. Have developed a plan to integrate evidence-based tobacco dependence treatment and policy that is tailored to their setting
  3. Within one year of completion, have a tobacco policy in place in their treatment setting and more evidence-based tobacco dependence treatment will be provided to patients.
Course summary
Registration opens: 
06/12/2021
Course expires: 
06/11/2024
Cost:
$0.00
Rating: 
0
Course 1Course 2
Module 1: What is Tobacco Integration? (required)Module 1: What is Evidence-based Treatment?
Module 2: How Integrated are You? (required)Module 2: FDA Approved Cessation Medications
Module 3: The Integration ProcessModule 3: Evidence-based Tobacco Dependence Treatment
Module 4: Does Setting Make a Difference?Module 4: Building Toward the Future: Using the EHR
Module 5: EnforcementModule 5:The Wisconsin Tobacco Quit Lline (WTQL)
Module 6: How to Help Staff Who Use TobaccoModule 6: E-Cigarettes
Maximum hours: 3.5Maximum hours: 2.5

 

 

 

 

 

 

 

 

 

 

 

 

Wach this video for a brief overview of the two courses:

Robert Adsit, MEd;
Director of Education and Outreach, UW-CTR

Please watch this two-minute video to begin:

David "Mac" Macmaster, CSAC, PTTS Managing Consultant;
Wisconsin Nicotine Treatment Integration Project (WiNTiP)

 

 

Bruce Christiansen, PhD*
Course Director, Content Developer, Planner, Reviewer

Meg Feyen, MS*
Reviewer
 

Eric Heiligenstein, MD
Content Developer, Faculty, Planner

Julie Reichert, MS
Faculty

Robert Adsit, MEd
Content Developer, Faculty, Reviewer

Michael C. Fiore, MD, MPH, MBA*
Content Developer, Faculty

Melissa Jackson
Faculty

Donna Riemer, RN-PMHN*
Content Developer, Reviewer

Ruby Ann Conrad, BS
Faculty

Randy Glysch, MS
Planner, Reviewer

Sandy Keller
Planner

Kathy Rohr, MSSW
Faculty

Roger Dier, MS
Faculty

Brenda Goettl, MA
Faculty

Kate Kobinsky, MPH
Faculty

Amy Skora, BS, CHES
Faculty

Laura Fabick, MSSW
Faculty

Allison Gorrilla, MPH
Faculty

Dave Macmaster, CSAC, PTTS
Content Developer, Faculty, Reviewer

Christine Ullstrup, LCSW, CSAC
Faculty

Katie R. Fassbinder, MD
Faculty

Kristine Hayden, BS
Faculty

Julie Martinelli, BS
CME Coordinator

Sheila Weix, MSN
Faculty

*2021 Renewal Planning Committee

POLICY ON DISCLOSURE

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies** held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers/presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation(s).

For this educational activity all conflicts of interests have been resolved and detailed disclosures are listed below:

Bruce Christiansen, PhD has no relevant relationships with ineligible companies to disclose
Robert Adsit, MEd has no relevant relationships with ineligible companies to disclose
Ruby Ann Conrad, BS has no relevant relationships to disclose in regard to this activity.
Roger Dier, MS has no relevant relationships with ineligible companies to disclose
Laura Fabick, MSSW has no relevant relationships with ineligible companies to disclose
Katie R. Fassbinder, MD has no relevant relationships with ineligible companies to disclose
Meg Feyen, MS has no relevant relationships with ineligible companies to disclose
Michael C. Fiore, MD, MPH, MBA has no relevant relationships with ineligible companies to disclose
Randy Glysch, MS has no relevant relationships with ineligible companies to disclose
Brenda Goettl, MA has no relevant relationships with ineligible companies to disclose
Allison Gorrilla, MPH has no relevant relationships with ineligible companies to disclose
Kristine Hayden, BS has no relevant relationships with ineligible companies to disclose
Eric Heiligenstein, MD has no relevant relationships with ineligible companies to disclose
Melissa Jackson has no relevant relationships with ineligible companies to disclose
Sandy Keller hhas no relevant relationships with ineligible companies to disclose
Kate Kobinsky, MPH has no relevant relationships with ineligible companies to disclose
Dave Macmaster, CSAC, PTTS has no relevant relationships with ineligible companies to disclose
Julie Reichert, MS has no relevant relationships with ineligible companies to disclose
Donna Riemer, RN-PMHN has no relevant relationships with ineligible companies to disclose
Kathy Rohr, MSSW has no relevant relationships with ineligible companies to disclose
Amy Skora, BS, CHES has no relevant relationships with ineligible companies to disclose
Christine Ullstrup, LCSW, CSAC has no relevant relationships with ineligible companies to disclose
Sheila Weix, MSN has no relevant relationships with ineligible companies to disclose
Julie Martinelli, BS has no relevant relationships with ineligible companies to disclose

**Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by, or on, patients. The ACCME does not consider providers of clinical services directly to patients to be commercial interests.

Discloser List CME Internal Report

Accreditation Statement

In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


 

 

 

 

 

 

See individual courses for credits offered.

 
Status
Price
Title
$0.00Included
Please login or register to take this course.
$0.00Included
Please login or register to take this course.

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Free, current version of Firefox, Safari, Chrome or Edge with audio. Some older browsers and Internet Explorer could produce error messages or not display the content correctly. 

Free, current version of Adobe Acrobat Reader or other .pdf reader